Suraksha Diagnostic IPO Peer Comparison: EPS, ROCE, ROE, P/E, P/Bv, Debt/Equity & RoNW

Suraksha Diagnostic IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details

IPO Details IPO GMP IPO Subscription Reviews About Company IPO Timeline KPI Financial Information Peer Comparison Allotment

Suraksha Diagnostic IPO: Comprehensive Peer Comparison with Healthcare Companies
This peer comparison evaluates Suraksha Diagnostic IPO against key competitors like Dr Lal PathLabs, Metropolis Healthcare, Thyrocare and Vijaya Diagnostic. By analysing essential financial metrics such as EPS, ROCE, ROE, P/E ratio, P/Bv, and Debt/Equity, investors can gain insights into the relative performance and valuation of these Healthcare companies. This comparison highlights the strengths and positioning of Suraksha Diagnostic in the competitive landscape of the Healthcare Industry.

Suraksha Diagnostic Limited IPO Peer Comparison
Company Name	EPS	ROCE	ROE	P/E (x)	P/Bv	Debt/Equity	RoNW (%)
Suraksha Diagnostic Limited	₹4.41	21.46%	14.09%	99.93	12.27	0.20	14.09%
Dr Lal PathLabs Limited	₹48.1	25.2%	20.4%	62.0	12.4	0.10	20.4%
Metropolis Healthcare Limited	₹28.9	15.8%	12.2%	74.1	9.26	0.16	12.2%
Thyrocare Technologies Limited	₹16.8	18.2%	13.3%	58.3	10.8	0.04	13.3%
Vijaya Diagnostic Centre Limited	₹12.9	19.5%	17.8%	88.7	16.4	0.40	17.8%